Our portfolio company, Fepod has empowered the healthcare professionals by developing a system that accurately measures real blood concentration directly from a drop of blood at the point-of-care.
We asked Jussi Pyysalo, CEO of Fepod, about Almarals part in their exceptional journey this far.
In what ways has Almaral provided support to Fepod?
Pyysalo: “The representatives from Almaral have been instrumental in offering essential support, particularly in the realm of strategic planning. Their provision of practical, situation-specific advice has been greatly appreciated. Moreover, their financial backing stands as a tangible form of assistance, one that has significantly contributed to our current success and promises to be an invaluable resource as we navigate our future endeavors”
How has Almaral helped you tackle obstacles that Fepod has faced this far?
Pyysalo: “A central attribute that aids us in overcoming challenges is Almaral’s capacity for agile response and swift action. This is cultivated through effective communication between our teams and Almaral’s experts, and is further strengthened by their comprehensive understanding of the diagnostics field”
How has Almaral contributed to Fepod’s achievement of its goals?
Pyysalo: “In our experience, the strategic offerings from Almaral have been instrumental in achieving our goals. Their strategy is grounded in realistic and concrete actions, made possible by the extensive experience of Almaral’s experts. The unique sector-specific expertise of Almaral’s professionals is reflected in our strategy, providing invaluable benefits in navigating various situations.”